Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurology Clinical Trial Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Bone Marrow
1.2.3 Epidermis
1.2.4 Mesenchymal Stem Cells
1.2.5 Haematopoietic Stem Cells
1.2.6 Chondrocytes
1.3 Market by Application
1.3.1 Global Neurology Clinical Trial Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Neurodegenerative Disorders
1.3.3 Cardiovascular Disorders
1.3.4 Orthopedics
1.3.5 Wound Healing
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurology Clinical Trial Market Perspective (2018-2033)
2.2 Neurology Clinical Trial Growth Trends by Region
2.2.1 Global Neurology Clinical Trial Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Neurology Clinical Trial Historic Market Size by Region (2018-2023)
2.2.3 Neurology Clinical Trial Forecasted Market Size by Region (2024-2033)
2.3 Neurology Clinical Trial Market Dynamics
2.3.1 Neurology Clinical Trial Industry Trends
2.3.2 Neurology Clinical Trial Market Drivers
2.3.3 Neurology Clinical Trial Market Challenges
2.3.4 Neurology Clinical Trial Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurology Clinical Trial Players by Revenue
3.1.1 Global Top Neurology Clinical Trial Players by Revenue (2018-2023)
3.1.2 Global Neurology Clinical Trial Revenue Market Share by Players (2018-2023)
3.2 Global Neurology Clinical Trial Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neurology Clinical Trial Revenue
3.4 Global Neurology Clinical Trial Market Concentration Ratio
3.4.1 Global Neurology Clinical Trial Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurology Clinical Trial Revenue in 2022
3.5 Neurology Clinical Trial Key Players Head office and Area Served
3.6 Key Players Neurology Clinical Trial Product Solution and Service
3.7 Date of Enter into Neurology Clinical Trial Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurology Clinical Trial Breakdown Data by Type
4.1 Global Neurology Clinical Trial Historic Market Size by Type (2018-2023)
4.2 Global Neurology Clinical Trial Forecasted Market Size by Type (2024-2033)
5 Neurology Clinical Trial Breakdown Data by Application
5.1 Global Neurology Clinical Trial Historic Market Size by Application (2018-2023)
5.2 Global Neurology Clinical Trial Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Neurology Clinical Trial Market Size (2018-2033)
6.2 North America Neurology Clinical Trial Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Neurology Clinical Trial Market Size by Country (2018-2023)
6.4 North America Neurology Clinical Trial Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurology Clinical Trial Market Size (2018-2033)
7.2 Europe Neurology Clinical Trial Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Neurology Clinical Trial Market Size by Country (2018-2023)
7.4 Europe Neurology Clinical Trial Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurology Clinical Trial Market Size (2018-2033)
8.2 Asia-Pacific Neurology Clinical Trial Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Neurology Clinical Trial Market Size by Region (2018-2023)
8.4 Asia-Pacific Neurology Clinical Trial Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neurology Clinical Trial Market Size (2018-2033)
9.2 Latin America Neurology Clinical Trial Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Neurology Clinical Trial Market Size by Country (2018-2023)
9.4 Latin America Neurology Clinical Trial Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurology Clinical Trial Market Size (2018-2033)
10.2 Middle East & Africa Neurology Clinical Trial Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Neurology Clinical Trial Market Size by Country (2018-2023)
10.4 Middle East & Africa Neurology Clinical Trial Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BrainStorm Cell Therapeutics
11.1.1 BrainStorm Cell Therapeutics Company Detail
11.1.2 BrainStorm Cell Therapeutics Business Overview
11.1.3 BrainStorm Cell Therapeutics Neurology Clinical Trial Introduction
11.1.4 BrainStorm Cell Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023)
11.1.5 BrainStorm Cell Therapeutics Recent Development
11.2 Opexa Therapeutics
11.2.1 Opexa Therapeutics Company Detail
11.2.2 Opexa Therapeutics Business Overview
11.2.3 Opexa Therapeutics Neurology Clinical Trial Introduction
11.2.4 Opexa Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023)
11.2.5 Opexa Therapeutics Recent Development
11.3 Caladrius Biosciences
11.3.1 Caladrius Biosciences Company Detail
11.3.2 Caladrius Biosciences Business Overview
11.3.3 Caladrius Biosciences Neurology Clinical Trial Introduction
11.3.4 Caladrius Biosciences Revenue in Neurology Clinical Trial Business (2018-2023)
11.3.5 Caladrius Biosciences Recent Development
11.4 U.S. Stem Cell
11.4.1 U.S. Stem Cell Company Detail
11.4.2 U.S. Stem Cell Business Overview
11.4.3 U.S. Stem Cell Neurology Clinical Trial Introduction
11.4.4 U.S. Stem Cell Revenue in Neurology Clinical Trial Business (2018-2023)
11.4.5 U.S. Stem Cell Recent Development
11.5 Lonza
11.5.1 Lonza Company Detail
11.5.2 Lonza Business Overview
11.5.3 Lonza Neurology Clinical Trial Introduction
11.5.4 Lonza Revenue in Neurology Clinical Trial Business (2018-2023)
11.5.5 Lonza Recent Development
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Detail
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Neurology Clinical Trial Introduction
11.6.4 Bristol Myers Squibb Revenue in Neurology Clinical Trial Business (2018-2023)
11.6.5 Bristol Myers Squibb Recent Development
11.7 Corning Incorporated
11.7.1 Corning Incorporated Company Detail
11.7.2 Corning Incorporated Business Overview
11.7.3 Corning Incorporated Neurology Clinical Trial Introduction
11.7.4 Corning Incorporated Revenue in Neurology Clinical Trial Business (2018-2023)
11.7.5 Corning Incorporated Recent Development
11.8 Vericel Corporation
11.8.1 Vericel Corporation Company Detail
11.8.2 Vericel Corporation Business Overview
11.8.3 Vericel Corporation Neurology Clinical Trial Introduction
11.8.4 Vericel Corporation Revenue in Neurology Clinical Trial Business (2018-2023)
11.8.5 Vericel Corporation Recent Development
11.9 Catalent
11.9.1 Catalent Company Detail
11.9.2 Catalent Business Overview
11.9.3 Catalent Neurology Clinical Trial Introduction
11.9.4 Catalent Revenue in Neurology Clinical Trial Business (2018-2023)
11.9.5 Catalent Recent Development
11.10 Lineage Cell Therapeutics
11.10.1 Lineage Cell Therapeutics Company Detail
11.10.2 Lineage Cell Therapeutics Business Overview
11.10.3 Lineage Cell Therapeutics Neurology Clinical Trial Introduction
11.10.4 Lineage Cell Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023)
11.10.5 Lineage Cell Therapeutics Recent Development
11.11 Castle Creek Biosciences
11.11.1 Castle Creek Biosciences Company Detail
11.11.2 Castle Creek Biosciences Business Overview
11.11.3 Castle Creek Biosciences Neurology Clinical Trial Introduction
11.11.4 Castle Creek Biosciences Revenue in Neurology Clinical Trial Business (2018-2023)
11.11.5 Castle Creek Biosciences Recent Development
11.12 Sangamo Therapeutics
11.12.1 Sangamo Therapeutics Company Detail
11.12.2 Sangamo Therapeutics Business Overview
11.12.3 Sangamo Therapeutics Neurology Clinical Trial Introduction
11.12.4 Sangamo Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023)
11.12.5 Sangamo Therapeutics Recent Development
11.13 Novartis
11.13.1 Novartis Company Detail
11.13.2 Novartis Business Overview
11.13.3 Novartis Neurology Clinical Trial Introduction
11.13.4 Novartis Revenue in Neurology Clinical Trial Business (2018-2023)
11.13.5 Novartis Recent Development
11.14 Holostem Terapie Avanzate S.R.L
11.14.1 Holostem Terapie Avanzate S.R.L Company Detail
11.14.2 Holostem Terapie Avanzate S.R.L Business Overview
11.14.3 Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Introduction
11.14.4 Holostem Terapie Avanzate S.R.L Revenue in Neurology Clinical Trial Business (2018-2023)
11.14.5 Holostem Terapie Avanzate S.R.L Recent Development
11.15 Pharmicell
11.15.1 Pharmicell Company Detail
11.15.2 Pharmicell Business Overview
11.15.3 Pharmicell Neurology Clinical Trial Introduction
11.15.4 Pharmicell Revenue in Neurology Clinical Trial Business (2018-2023)
11.15.5 Pharmicell Recent Development
11.16 Tego Science
11.16.1 Tego Science Company Detail
11.16.2 Tego Science Business Overview
11.16.3 Tego Science Neurology Clinical Trial Introduction
11.16.4 Tego Science Revenue in Neurology Clinical Trial Business (2018-2023)
11.16.5 Tego Science Recent Development
11.17 Autolus therapeutics
11.17.1 Autolus therapeutics Company Detail
11.17.2 Autolus therapeutics Business Overview
11.17.3 Autolus therapeutics Neurology Clinical Trial Introduction
11.17.4 Autolus therapeutics Revenue in Neurology Clinical Trial Business (2018-2023)
11.17.5 Autolus therapeutics Recent Development
11.18 Bayer AG
11.18.1 Bayer AG Company Detail
11.18.2 Bayer AG Business Overview
11.18.3 Bayer AG Neurology Clinical Trial Introduction
11.18.4 Bayer AG Revenue in Neurology Clinical Trial Business (2018-2023)
11.18.5 Bayer AG Recent Development
11.19 Sartorius AG
11.19.1 Sartorius AG Company Detail
11.19.2 Sartorius AG Business Overview
11.19.3 Sartorius AG Neurology Clinical Trial Introduction
11.19.4 Sartorius AG Revenue in Neurology Clinical Trial Business (2018-2023)
11.19.5 Sartorius AG Recent Development
11.20 Daiichi Sankyo
11.20.1 Daiichi Sankyo Company Detail
11.20.2 Daiichi Sankyo Business Overview
11.20.3 Daiichi Sankyo Neurology Clinical Trial Introduction
11.20.4 Daiichi Sankyo Revenue in Neurology Clinical Trial Business (2018-2023)
11.20.5 Daiichi Sankyo Recent Development
11.21 Takeda Pharmaceutical Company
11.21.1 Takeda Pharmaceutical Company Company Detail
11.21.2 Takeda Pharmaceutical Company Business Overview
11.21.3 Takeda Pharmaceutical Company Neurology Clinical Trial Introduction
11.21.4 Takeda Pharmaceutical Company Revenue in Neurology Clinical Trial Business (2018-2023)
11.21.5 Takeda Pharmaceutical Company Recent Development
11.22 Sumitomo Chemical Co
11.22.1 Sumitomo Chemical Co Company Detail
11.22.2 Sumitomo Chemical Co Business Overview
11.22.3 Sumitomo Chemical Co Neurology Clinical Trial Introduction
11.22.4 Sumitomo Chemical Co Revenue in Neurology Clinical Trial Business (2018-2023)
11.22.5 Sumitomo Chemical Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Neurology Clinical Trial Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Bone Marrow
Table 3. Key Players of Epidermis
Table 4. Key Players of Mesenchymal Stem Cells
Table 5. Key Players of Haematopoietic Stem Cells
Table 6. Key Players of Chondrocytes
Table 7. Global Neurology Clinical Trial Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Neurology Clinical Trial Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Neurology Clinical Trial Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Neurology Clinical Trial Market Share by Region (2018-2023)
Table 11. Global Neurology Clinical Trial Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Neurology Clinical Trial Market Share by Region (2024-2033)
Table 13. Neurology Clinical Trial Market Trends
Table 14. Neurology Clinical Trial Market Drivers
Table 15. Neurology Clinical Trial Market Challenges
Table 16. Neurology Clinical Trial Market Restraints
Table 17. Global Neurology Clinical Trial Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Neurology Clinical Trial Market Share by Players (2018-2023)
Table 19. Global Top Neurology Clinical Trial Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurology Clinical Trial as of 2022)
Table 20. Ranking of Global Top Neurology Clinical Trial Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Neurology Clinical Trial Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Neurology Clinical Trial Product Solution and Service
Table 24. Date of Enter into Neurology Clinical Trial Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neurology Clinical Trial Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Neurology Clinical Trial Revenue Market Share by Type (2018-2023)
Table 28. Global Neurology Clinical Trial Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Neurology Clinical Trial Revenue Market Share by Type (2024-2033)
Table 30. Global Neurology Clinical Trial Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Neurology Clinical Trial Revenue Market Share by Application (2018-2023)
Table 32. Global Neurology Clinical Trial Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Neurology Clinical Trial Revenue Market Share by Application (2024-2033)
Table 34. North America Neurology Clinical Trial Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Neurology Clinical Trial Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Neurology Clinical Trial Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Neurology Clinical Trial Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Neurology Clinical Trial Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Neurology Clinical Trial Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Neurology Clinical Trial Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Neurology Clinical Trial Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Neurology Clinical Trial Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Neurology Clinical Trial Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Neurology Clinical Trial Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Neurology Clinical Trial Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Neurology Clinical Trial Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Neurology Clinical Trial Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Neurology Clinical Trial Market Size by Country (2024-2033) & (US$ Million)
Table 49. BrainStorm Cell Therapeutics Company Detail
Table 50. BrainStorm Cell Therapeutics Business Overview
Table 51. BrainStorm Cell Therapeutics Neurology Clinical Trial Product
Table 52. BrainStorm Cell Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 53. BrainStorm Cell Therapeutics Recent Development
Table 54. Opexa Therapeutics Company Detail
Table 55. Opexa Therapeutics Business Overview
Table 56. Opexa Therapeutics Neurology Clinical Trial Product
Table 57. Opexa Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 58. Opexa Therapeutics Recent Development
Table 59. Caladrius Biosciences Company Detail
Table 60. Caladrius Biosciences Business Overview
Table 61. Caladrius Biosciences Neurology Clinical Trial Product
Table 62. Caladrius Biosciences Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 63. Caladrius Biosciences Recent Development
Table 64. U.S. Stem Cell Company Detail
Table 65. U.S. Stem Cell Business Overview
Table 66. U.S. Stem Cell Neurology Clinical Trial Product
Table 67. U.S. Stem Cell Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 68. U.S. Stem Cell Recent Development
Table 69. Lonza Company Detail
Table 70. Lonza Business Overview
Table 71. Lonza Neurology Clinical Trial Product
Table 72. Lonza Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 73. Lonza Recent Development
Table 74. Bristol Myers Squibb Company Detail
Table 75. Bristol Myers Squibb Business Overview
Table 76. Bristol Myers Squibb Neurology Clinical Trial Product
Table 77. Bristol Myers Squibb Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 78. Bristol Myers Squibb Recent Development
Table 79. Corning Incorporated Company Detail
Table 80. Corning Incorporated Business Overview
Table 81. Corning Incorporated Neurology Clinical Trial Product
Table 82. Corning Incorporated Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 83. Corning Incorporated Recent Development
Table 84. Vericel Corporation Company Detail
Table 85. Vericel Corporation Business Overview
Table 86. Vericel Corporation Neurology Clinical Trial Product
Table 87. Vericel Corporation Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 88. Vericel Corporation Recent Development
Table 89. Catalent Company Detail
Table 90. Catalent Business Overview
Table 91. Catalent Neurology Clinical Trial Product
Table 92. Catalent Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 93. Catalent Recent Development
Table 94. Lineage Cell Therapeutics Company Detail
Table 95. Lineage Cell Therapeutics Business Overview
Table 96. Lineage Cell Therapeutics Neurology Clinical Trial Product
Table 97. Lineage Cell Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 98. Lineage Cell Therapeutics Recent Development
Table 99. Castle Creek Biosciences Company Detail
Table 100. Castle Creek Biosciences Business Overview
Table 101. Castle Creek Biosciences Neurology Clinical Trial Product
Table 102. Castle Creek Biosciences Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 103. Castle Creek Biosciences Recent Development
Table 104. Sangamo Therapeutics Company Detail
Table 105. Sangamo Therapeutics Business Overview
Table 106. Sangamo Therapeutics Neurology Clinical Trial Product
Table 107. Sangamo Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 108. Sangamo Therapeutics Recent Development
Table 109. Novartis Company Detail
Table 110. Novartis Business Overview
Table 111. Novartis Neurology Clinical Trial Product
Table 112. Novartis Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 113. Novartis Recent Development
Table 114. Holostem Terapie Avanzate S.R.L Company Detail
Table 115. Holostem Terapie Avanzate S.R.L Business Overview
Table 116. Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Product
Table 117. Holostem Terapie Avanzate S.R.L Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 118. Holostem Terapie Avanzate S.R.L Recent Development
Table 119. Pharmicell Company Detail
Table 120. Pharmicell Business Overview
Table 121. Pharmicell Neurology Clinical Trial Product
Table 122. Pharmicell Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 123. Pharmicell Recent Development
Table 124. Tego Science Company Detail
Table 125. Tego Science Business Overview
Table 126. Tego Science Neurology Clinical Trial Product
Table 127. Tego Science Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 128. Tego Science Recent Development
Table 129. Autolus therapeutics Company Detail
Table 130. Autolus therapeutics Business Overview
Table 131. Autolus therapeutics Neurology Clinical Trial Product
Table 132. Autolus therapeutics Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 133. Autolus therapeutics Recent Development
Table 134. Bayer AG Company Detail
Table 135. Bayer AG Business Overview
Table 136. Bayer AG Neurology Clinical Trial Product
Table 137. Bayer AG Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 138. Bayer AG Recent Development
Table 139. Sartorius AG Company Detail
Table 140. Sartorius AG Business Overview
Table 141. Sartorius AG Neurology Clinical Trial Product
Table 142. Sartorius AG Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 143. Sartorius AG Recent Development
Table 144. Daiichi Sankyo Company Detail
Table 145. Daiichi Sankyo Business Overview
Table 146. Daiichi Sankyo Neurology Clinical Trial Product
Table 147. Daiichi Sankyo Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 148. Daiichi Sankyo Recent Development
Table 149. Takeda Pharmaceutical Company Company Detail
Table 150. Takeda Pharmaceutical Company Business Overview
Table 151. Takeda Pharmaceutical Company Neurology Clinical Trial Product
Table 152. Takeda Pharmaceutical Company Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 153. Takeda Pharmaceutical Company Recent Development
Table 154. Sumitomo Chemical Co Company Detail
Table 155. Sumitomo Chemical Co Business Overview
Table 156. Sumitomo Chemical Co Neurology Clinical Trial Product
Table 157. Sumitomo Chemical Co Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 158. Sumitomo Chemical Co Recent Development
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurology Clinical Trial Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Neurology Clinical Trial Market Share by Type: 2022 VS 2033
Figure 3. Bone Marrow Features
Figure 4. Epidermis Features
Figure 5. Mesenchymal Stem Cells Features
Figure 6. Haematopoietic Stem Cells Features
Figure 7. Chondrocytes Features
Figure 8. Global Neurology Clinical Trial Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Neurology Clinical Trial Market Share by Application: 2022 VS 2033
Figure 10. Neurodegenerative Disorders Case Studies
Figure 11. Cardiovascular Disorders Case Studies
Figure 12. Orthopedics Case Studies
Figure 13. Wound Healing Case Studies
Figure 14. Other Case Studies
Figure 15. Neurology Clinical Trial Report Years Considered
Figure 16. Global Neurology Clinical Trial Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Neurology Clinical Trial Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Neurology Clinical Trial Market Share by Region: 2022 VS 2033
Figure 19. Global Neurology Clinical Trial Market Share by Players in 2022
Figure 20. Global Top Neurology Clinical Trial Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurology Clinical Trial as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Neurology Clinical Trial Revenue in 2022
Figure 22. North America Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Neurology Clinical Trial Market Share by Country (2018-2033)
Figure 24. United States Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Neurology Clinical Trial Market Share by Country (2018-2033)
Figure 28. Germany Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Neurology Clinical Trial Market Share by Region (2018-2033)
Figure 36. China Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Neurology Clinical Trial Market Share by Country (2018-2033)
Figure 44. Mexico Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Neurology Clinical Trial Market Share by Country (2018-2033)
Figure 48. Turkey Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. BrainStorm Cell Therapeutics Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 51. Opexa Therapeutics Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 52. Caladrius Biosciences Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 53. U.S. Stem Cell Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 54. Lonza Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 55. Bristol Myers Squibb Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 56. Corning Incorporated Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 57. Vericel Corporation Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 58. Catalent Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 59. Lineage Cell Therapeutics Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 60. Castle Creek Biosciences Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 61. Sangamo Therapeutics Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 62. Novartis Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 63. Holostem Terapie Avanzate S.R.L Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 64. Pharmicell Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 65. Tego Science Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 66. Autolus therapeutics Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 67. Bayer AG Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 68. Sartorius AG Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 69. Daiichi Sankyo Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 70. Takeda Pharmaceutical Company Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 71. Sumitomo Chemical Co Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed